Back to Trials
NCT02780297Recruiting

Prospective Research Rare Kidney Stones (ProRKS)

Mayo Clinic

Start Date

5/1/2016

Completion Date

7/1/2026

Summary

The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria, Dent disease and adenine phosphoribosyltransferase deficiency (APRTd) and acquired enteric hyperoxaluria (EH). The investigator will measure blood and urinary markers of inflammation and determine relationship to the disease course. Cross-comparisons among the disorders will allow us to better evaluate mechanisms of renal dysfunction in these disorders.

Detailed Description

Severe, hereditary forms of nephrolithiasis cause marked excretion of insoluble minerals important in stone formation, including primary hyperoxaluria, cystinuria, Dent disease, and adenine phosphoribosyltransferase deficiency (APRTd). Patients with these disorders experience recurring stones from childhood and are at high risk for chronic kidney disease caused by crystal nephropathy. Enteric hyperoxaluria is an acquired disease characterized by hyperoxaluria and calcium oxalate crystal nephropathy associated with chronic kidney disease, and in that respect similar to the inherited stone diseases. The investigators will collect longitudinal data of individual patients in order to provide clues about potentially modifiable factors that influence disease severity and identify factors leading to kidney injury. the investigator will measure blood and urinary markers of inflammation and determine relationship to the disease course. Cross-comparisons among the disorders will allow to better evaluate mechanisms of renal dysfunction in these diseases.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: 1. Diagnosis of primary hyperoxaluria 2. Diagnosis of enteric hyperoxaluria 3. Diagnosis of Dent Disease 4. Diagnosis of Cystinuria 5. Diagnosis of adenine phosphoribosyltransferase deficiency (APRTd) 6. Diagnosis of Lowe Syndrome 7. Diagnosis of Dent Disease Carrier Exclusion Criteria: 1. Prior renal failure 2. History of liver and/or kidney transplant.

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

HyperoxaluriaCystinuriaDent DiseaseLowe SyndromeAdenine Phosphoribosyltransferase Deficiency

Locations

University of Alabama @ Birmingham

Birmingham, Alabama 35294

United States

Mayo Clinic Jacksonville

Jacksonville, Florida 32224

United States

Children's Memorial Hospital

Chicago, Illinois 60614

United States

Children's Hospital, Harvard Medical School

Boston, Massachusetts 02115

United States

Mayo Clinic Hyperoxaluria Center

Rochester, Minnesota 55905

United States

New York University

New York, New York 10010

United States

Cincinnati Children's Hosptial Medical Center

Cincinnati, Ohio 45229

United States

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania 19104

United States

Hosptial of Sick Children

Toronto, Ontario M5G 1X8

Canada

Landspitali Universtiy Hospital

Reykjavik,

Iceland

Shaare Zedek Medica Center

Jerusalem,

Israel